Clairo

Account VP, Business Development

United Kingdom

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Imaging, Healthcare, Medical Devices, Clinical TrialsIndustries

Requirements

Candidates should possess a Bachelor’s degree and possess 10+ years of experience in business development, with a proven track record of success in sales and account management. Strong leadership skills, strategic thinking, and excellent communication abilities are essential, along with the ability to identify business opportunities and develop client relationships.

Responsibilities

The Account VP, Business Development will generate new leads and prospects through research and outreach, prospect qualified sales leads, manage corporate meetings and exhibitions, develop and secure business through RFPs and contract negotiation, maintain client relationships by providing support and recommendations, and maximize market penetration by understanding market trends and competitor offerings. They will also assist in establishing departmental standards, maintain technical knowledge through training, and adhere to organizational SOPs.

Skills

Business Development
Client Relationship Management
Sales Pipeline Development
Proposal Writing
Contract Negotiation
Market Analysis
Lead Generation
Prospecting
Negotiation
Industry Networking

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

Key Metrics

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI